Astellas Gene Therapies
Overview
Astellas Gene Therapies is a biotechnology company headquartered in San Francisco, United States, founded in 2012, with 201-500 employees.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Astellas Gene Therapies in our records. PharmaTek screens the full directory against live FDA enforcement data.
Verified Supplier Partner
Is this Astellas Gene Therapies? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
3D Imaging Drug Design and Development LLC
United States
A&B Pharmaceuticals
United States
Abgenix, Inc.
United States
Aegerion Pharmaceuticals, Inc.
United States
Alexion Pharmaceuticals, Inc.
United States
Amicus Therapeutics, Inc.
United States
Anesol Pharmaceuticals Inc.
United States
Apollomics Inc.
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.